Convatec (LSE:CTEC), a leading medical products and technologies company focused on solutions for the management of chronic conditions; The Eli Lilly and Company Foundation (Lilly Foundation), a tax-exempt private foundation supported by donations from Eli Lilly and Company (NYSE:LLY) have committed c.$5 million to Partners In Health (PIH), an international nonprofit global health organization to help accelerate the integration of non‑communicable disease (NCD) and chronic care, including cardiometabolic and mental health, into primary and community health systems in resource-limited settings.

The financial commitment will enable PIH to scale its integrated models of care and support efforts to embed sustainable approaches to the prevention, diagnosis and management of NCDs and other chronic conditions within shifting healthcare systems.

For Convatec, the commitment represents the next phase of its collaboration with PIH, building on work since 2023 that has already reached more than 300,000 people. The initiative honours the legacy of Karim Bitar, formerly Chief Executive Officer of Convatec before he passed away in October 2025, whose belief in the power of collective action and long‑term healthcare partnerships continues to inspire many people.

The focus of the next phase related to Convatec's collaboration will continue scaling innovative approaches to training and deploying Community Health Workers (CHWs), supporting high‑quality, locally delivered care for people living with chronic conditions, and strengthening referral pathways within health systems. This work will support PIH programmes across multiple geographies, including Peru and Rwanda, while continuing to engage Convatec leaders in leadership development, building on work started in 2025.

In addition, this phase will introduce new collaboration with PIH's university site, the University of Global Health Equity in Rwanda. This work aims to help prepare the next generation of changemakers to build equitable health systems that can respond to the growing burden of chronic and long‑term conditions through innovation, research and clinical evidence.

The charitable work of PIH supported by the Lilly Foundation grant is the integration of cardiometabolic and other NCD care into primary care systems in resource-limited settings in Rwanda, Malawi, and Sierra Leone. PIH will support system‑level strengthening, including training frontline health workers, increasing early diagnosis and improving continuity and quality of care.